Cogent Biosciences Inc (NASDAQ: COGT) closed the day trading at $6.73 down -0.15% from the previous closing price of $6.74. In other words, the price has decreased by -$0.01 from its previous closing price. On the day, 1377022 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of COGT, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.09 and its Current Ratio is at 7.09. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.07.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Robert W. Baird on February 26, 2024, Downgraded its rating to Neutral and sets its target price to $8 from $14 previously.
On February 08, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $11.
Wedbush Downgraded its Outperform to Neutral on December 11, 2023, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 09 ’23 when Fairmount Funds Management LLC bought 800,000 shares for $12.00 per share. The transaction valued at 9,600,000 led to the insider holds 3,272,124 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, COGT now has a Market Capitalization of 700.38M and an Enterprise Value of 513.55M.
Stock Price History:
The Beta on a monthly basis for COGT is 1.53, which has changed by -33.23% over the last 52 weeks, in comparison to a change of 31.54% over the same period for the S&P500. Over the past 52 weeks, COGT has reached a high of $13.50, while it has fallen to a 52-week low of $3.67. The 50-Day Moving Average of the stock is 6.19, while the 200-Day Moving Average is calculated to be 9.03.
Shares Statistics:
Over the past 3-months, COGT traded about 2.27M shares per day on average, while over the past 10 days, COGT traded about 2.01M shares per day. A total of 103.91M shares are outstanding, with a floating share count of 87.22M. Insiders hold about 16.06% of the company’s shares, while institutions hold 75.78% stake in the company. Shares short for COGT as of Feb 29, 2024 were 9.07M with a Short Ratio of 3.99, compared to 5.04M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.73% and a Short% of Float of 8.97%.
Earnings Estimates
Current recommendations for the stock of the company come from 9 analysts. On average, analysts expect EPS of -$0.51 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.59, while EPS last year was -$0.54. The consensus estimate for the next quarter is -$0.49, with high estimates of -$0.33 and low estimates of -$0.59.
Analysts are recommending an EPS of between -$1.41 and -$2.42 for the fiscal current year, implying an average EPS of -$2. EPS for the following year is -$1.99, with 8 analysts recommending between -$1.39 and -$2.7.
